Status
ClosedCategory
Awareness and Diagnosis; TreatmentTiming
Thursday, 27 November 2025, 15:30-17:00 CETResources
» Teresa Macarulla Presentation
The Webinar:
In line with its mission to provide knowledge and resources to patients, families, and healthcare professionals, Pancreatic Cancer Europe (PCE) and the European Pancreatic Club (EPC) dedicated the 2025 webinar, held as part of World Pancreatic Cancer Awareness Month, to clinical trials as a key element in the development of innovative treatments. Building on the success of previous initiatives, this programme highlighted the importance of clinical trials in advancing cancer care, ensuring patient safety, and shaping better treatments for the future.
Based on experiences shared by patients, survivors, caregivers, and healthcare professionals, PCE and EPC developed this initiative to raise awareness of the opportunities and challenges associated with clinical trials.
Programme:
Opening and Welcome
- Ilse Rooman, Pancreatic Cancer Europe (PCE) Board of Directors, Belgium
- Nicolás González Casares, Member of European Parliament, Belgium
Keynote Speeches
- What is a clinical trial
Teresa Macarulla, Hospital Clínic Barcelona, Head of the Medical Oncology Department, Spain - The innovation that clinical trials bring to pancreatic cancer treatment
Ingrid Garajova, EORTC – European Organisation for Research and Treatment of Cancer, Pancreatic Cancer Task Force, Belgium
Q&A
Panel Discussion
- Dan McNamee, patient and survivor, France
- Talia Golan, medical oncologist, Sheba Medical Centre, Israel
- IJsbrand den Rooijen, health data scientist, EMA – European Medicines Agency, The Netherlands
Q&A
The Treatment Opportunities for Pancreatic Cancer Project
- Florian Castet, Vall d’Hebron University Hospital, Gastrointestinal Cancer Unit, Spain
Conclusions and Final Remarks
- Gabriele Capurso, EPC General Secretary, Austria
Closing of the Event